Condition
Gut Biome
Total Trials
2
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
Treatment Research
1 treatments under study, led by Gut Microbiome Analysis
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Unknown1
Not Yet Recruiting1
Clinical Trials (2)
Research Network
Common Treatments
- Gut Microbiome Analysis1
Active Sponsors
- University of Virginia1
- Peking Union Medical College Hospital1
- National Institute on Aging (NIA)1
Related Conditions
- Dlbcl1
- Alzheimer Disease1
- Glofitamab1